Ulcerative Colitis Clinical Trials in Coronado, California

5 studies are recruiting for ulcerative colitis in Coronado, California right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)

    The purpose of this protocol is to evaluate the efficacy of MK-8690 in participants with moderately to severely active ulcerative colitis. The primary hypothesis is that MK-8690 is superior to placebo with respect to the proportion of participants achieving clinical remission per Modified Mayo Scor…

    Stage
    Phase 2
    Ages
    18 to 75
    Site
    Southern California Research Center ( Site 1044), Coronado, California
    Locations
    35 in total
    Run by
    Merck Sharp & Dohme LLC

    See if you can join NCT07463183 on ClinicalTrials.gov

  2. Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

    Crohn's disease (CD) and Ulcerative colitis (UC) are 2 types of inflammatory bowel diseases which cause long-lasting, severe inflammation (redness, swelling) in the digestive tract. CD can affect any part of the digestive tract causing many different symptoms including belly pain, diarrhea, tiredne…

    Stage
    Phase 2
    Ages
    18 to 75
    Site
    Southern California Res. Ctr /ID# 280476, Coronado, California
    Locations
    36 in total
    Run by
    AbbVie

    See if you can join NCT07697456 on ClinicalTrials.gov

  3. A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

    This is a multicenter, randomized, double-blind, placebo-controlled Phase 3 maintenance study to evaluate the efficacy and safety of duvakitug in participants with moderately to severely active Ulcerative Colitis (UC). Study details include: The study duration may be up to 286 weeks including: * 40…

    Stage
    Phase 3
    Ages
    16 to 80
    Site
    Southern California GI & Liver Centers - Site Number: 8400062, Coronado, California
    Locations
    55 in total
    Run by
    Sanofi

    See if you can join NCT07185009 on ClinicalTrials.gov

  4. An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

    This is a multinational, multicenter, randomized, double-blind, placebo-controlled, Phase 3 induction study to evaluate the efficacy and safety of duvakitug in participants with moderately to severely active Ulcerative Colitis (UC). Study details include: The study duration may be up to 35 weeks wi…

    Stage
    Phase 3
    Ages
    16 to 80
    Site
    Southern California GI & Liver Centers - Site Number: 8400062, Coronado, California
    Locations
    219 in total
    Run by
    Sanofi

    See if you can join NCT07184996 on ClinicalTrials.gov

  5. A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

    The main purpose of this study is to determine the safety and efficacy of eltrekibart and mirikizumab in adult participants with moderately to severely active ulcerative colitis (UC).

    Stage
    Phase 2
    Ages
    18 to 75
    Site
    Southern California GI and Liver Centers (SCLC), Coronado, California
    Locations
    207 in total
    Run by
    Eli Lilly and Company

    See if you can join NCT06598943 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.